kabutan

NIPPON CHEMIPHAR CO., LTD.(4539) Summary

4539
TSE Standard
NIPPON CHEMIPHAR CO., LTD.
1,738
JPY
+9
(+0.52%)
Mar 13, 9:42 am JST
10.91
USD
Mar 12, 8:42 pm EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
42.0
PBR
0.33
Yield
2.88%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:26 am
1,738 JPY 10.92 USD
Previous Close Mar 12
1,729 JPY 10.87 USD
High Mar 13, 9:26 am
1,738 JPY 10.92 USD
Low Mar 13, 9:26 am
1,738 JPY 10.91 USD
Volume
300
Trading Value
1.00M JPY 3.26K USD
VWAP
1738.0 JPY 10.87 USD
Minimum Trading Value
173,800 JPY 1,091 USD
Market Cap
7.41B JPY 0.05B USD
Number of Trades
2
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly Low
1-Year Average
13
1-Year High Sep 11, 2025
83
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 177,900
Feb 27, 2026 0 178,400
Feb 20, 2026 0 180,400
Feb 13, 2026 0 177,700
Feb 6, 2026 0 176,100
Company Profile
NIPPON CHEMIPHAR CO., LTD. is a mid-sized pharmaceutical company. Its main focus is on generic drugs, with uric acid and pain relief medications as its core products. The company is also actively engaged in new drug development.
Sector
Pharmaceuticals
NIPPON CHEMIPHAR CO., LTD. operates in the medical, health, and beauty-related sectors, with pharmaceutical products at its core. In its primary pharmaceutical business, the company manufactures and sells prescription drugs, with a high proportion of generic medicines, while also pursuing new drug development. The company promotes its business in collaboration with domestic and overseas subsidiaries and affiliates. Additionally, it is involved in other ventures such as safety testing services, healthcare business, and real estate leasing. The group comprises six companies, establishing an integrated system from drug development to manufacturing and sales. While maintaining its strength in the prescription drug field, NIPPON CHEMIPHAR CO., LTD. has expanded into related areas, solidifying its position as a comprehensive medical and health-related enterprise.